For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

"Hearst Magazines and AOL may earn commission or revenue on some items through these links." As we age, so do our cells. But some scientists are wondering if we actually need to accept this inevitable ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...